These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 11487776

  • 21. Nucleolar organizer regions as discriminators for the diagnosis of well-differentiated adenocarcinoma of the prostate.
    Schned AR.
    Arch Pathol Lab Med; 1993 Oct; 117(10):1000-4. PubMed ID: 8215819
    [Abstract] [Full Text] [Related]

  • 22. AgNOR (nucleolar organizer regions) staining in malignant melanoma.
    Nagatani T, Iemoto G, Miyakawa K, Ichiyama S, Takahashi Y, Uchiyama M, Nakajima H.
    J Dermatol; 1991 Dec; 18(12):731-5. PubMed ID: 1806604
    [Abstract] [Full Text] [Related]

  • 23. [Thyroid pathology: evaluation of the average value of NORs and its potential diagnostic and prognostic application].
    Iuele R, Gallippi G, Giacchetto C.
    Pathologica; 1994 Oct; 86(5):525-7. PubMed ID: 7739878
    [Abstract] [Full Text] [Related]

  • 24. [Study of silver binding nucleolar organizer regions (AgNORs) in proliferative lesions of bronchi, colon and thyroid--semiautomatic computer image analysis].
    Zaczek M.
    Folia Med Cracov; 1996 Oct; 37(1-2):67-88. PubMed ID: 9312528
    [Abstract] [Full Text] [Related]

  • 25. [Nucleolar organizer regions of benign pathology of the parathyroids].
    Colecchia M, Zucchi A, Prian E, Leopardi O.
    Pathologica; 1993 Oct; 85(1100):667-77. PubMed ID: 8170716
    [Abstract] [Full Text] [Related]

  • 26. Identification and assessment of nucleolar organizer regions (NORs)--technical problems.
    Zaczek M, Dabroś E, Maciejowski J, Szot W.
    Pol J Pathol; 1994 Oct; 45(1):35-8. PubMed ID: 7513845
    [Abstract] [Full Text] [Related]

  • 27. [Silver-stained Nucleolar Organizer Regions (AgNOR)].
    Derenzini M, Trerè D.
    Pathologica; 2001 Apr; 93(2):99-105. PubMed ID: 11428299
    [Abstract] [Full Text] [Related]

  • 28. Nucleolar organizer regions (AgNORs) in primary and recurrent gliomas. A retrospective study.
    Engel U, Plate K, Jänisch W, Mennel HD.
    Zentralbl Pathol; 1994 Mar; 140(1):73-81. PubMed ID: 7515677
    [Abstract] [Full Text] [Related]

  • 29. Nucleolar organizer regions (NORs) in dysplastic and neoplastic epithelial lesions of the conjunctiva.
    Muscarà M, Giuffré G, Trombetta CJ, Bisantis F, Tuccari G.
    Pathologica; 1991 Mar; 83(1085):281-8. PubMed ID: 1923626
    [Abstract] [Full Text] [Related]

  • 30. Nucleolar organizer regions in laryngeal cancer.
    Klatka J, Skomra D.
    Ann Univ Mariae Curie Sklodowska Med; 2001 Mar; 56():417-21. PubMed ID: 11977351
    [Abstract] [Full Text] [Related]

  • 31. Nucleolar organizer regions in cutaneous tumours.
    Egan MJ, Crocker J.
    J Pathol; 1988 Mar; 154(3):247-53. PubMed ID: 2450982
    [Abstract] [Full Text] [Related]

  • 32. Significance of silver-stained nucleolar organizer regions in early diagnosis and prognosis of oral squamous cell carcinoma: a multivariate analysis.
    Pillai KR, Sujathan K, Madhavan J, Abraham EK.
    In Vivo; 2005 Mar; 19(4):807-12. PubMed ID: 16001464
    [Abstract] [Full Text] [Related]

  • 33. Expression of tenascin and nucleolar organizer region in ameloblastoma and ameloblastic fibroma.
    Carnelio S, Vij H.
    J Oral Pathol Med; 2010 Mar; 39(3):223-9. PubMed ID: 19943856
    [Abstract] [Full Text] [Related]

  • 34. [The analysis of nuclear organizer regions of astrocytomas with various histologic malignancies].
    Tokiyoshi K, Yoshimine T, Maruno M, Nakagawa H, Iwata Y, Kuroda R, Hayakawa T.
    No To Shinkei; 1992 Dec; 44(12):1083-6. PubMed ID: 1296727
    [Abstract] [Full Text] [Related]

  • 35. Assessment of argyrophilic nucleolar organizer region quantification in benign and malignant bone tumors.
    Clohisy JC, Schajowicz F, Vaziri DM, McDonald DJ, Connolly TJ, Sotelo-Avila C, Betts JE.
    Clin Orthop Relat Res; 1995 Jan; (310):229-36. PubMed ID: 7641444
    [Abstract] [Full Text] [Related]

  • 36. A sensitive staining method for NORs.
    Yekeler H, Erel O, Yumbul AZ, Doymaz MZ, Doğan O, Ozercan MR, Iplikçi A.
    J Pathol; 1995 Apr; 175(4):449-52. PubMed ID: 7540686
    [Abstract] [Full Text] [Related]

  • 37. Counting the nucleolar organizer region-associated proteins is a prognostic clue of malignant melanoma.
    Gambini C, Casazza S, Borgiani L, Canepa M, Rovida S, Rongioletti F, Rebora A.
    Arch Dermatol; 1992 Apr; 128(4):487-90. PubMed ID: 1580655
    [Abstract] [Full Text] [Related]

  • 38. Prognostic significance of nucleolar organizer regions (NORS) in malignant melanoma.
    Ronan SG, Farolan MJ, McDonald A, Manaligod JR, Das Gupta TK.
    J Cutan Pathol; 1994 Dec; 21(6):494-9. PubMed ID: 7699115
    [Abstract] [Full Text] [Related]

  • 39. Prognostic value of argyrophylic nucleolar organiser regions (AgNORs) in breast lesions.
    Simha M, Menon M, Doctor V.
    Indian J Cancer; 1996 Jun; 33(2):76-85. PubMed ID: 8979469
    [Abstract] [Full Text] [Related]

  • 40. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
    Klobusická M, Kusenda J, Babusíková O.
    Neoplasma; 2003 Jun; 50(6):408-15. PubMed ID: 14689061
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.